speb/financial-data huggingface dataset:
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 4760131000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 123280000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 7135658000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Current Assets: 3225143000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 0.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Current Debt: 270268000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 270268000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 1799693000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Depreciation: 149659000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 152333000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 152333000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 149659000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 51844960.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Diluted EPS: 20.82
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 1079389000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 17220000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 2269000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — EBIT: 1500429000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — EBITDA: 1652762000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — End Cash Position: 300676000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 707787000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 337123000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -656336000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -11035000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 92379000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 4367000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 1410744000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 4774792000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Gross Profit: 3557018000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Interest Expense: 45282000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 45282000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Interest Income: 4688000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 4688000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -50582000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 4439000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Inventory: 1050897000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 6278045000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -1793372000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 15121000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 731608000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 1018373000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 91854000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 0.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 1247646000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 1247646000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 1018373000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -66992000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 34154000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 3170485000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Net Debt: 1365208000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 1898000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Net Income: 1079389000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 1079389000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 1079388000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 1079389000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 1079389000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 1455147000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 1079388000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Net Interest Income: -45894000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 67609000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 1016759000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 951381000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -45894000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 1582000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Net PPE: 3956919000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -1869271000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 65378000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 4755764000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 122492000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 34154000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 101252000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 1643054000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Normalized Income: 1072187872.76
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 1213556000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Operating Income: 1434323000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Operating Revenue: 10692676000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 51844960.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 352777000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 3188000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 4656441000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 4367000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 14598000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 44312000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 1000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 2309000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 1029396000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Other Payable: 411144000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Other Properties: 645588000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 99023000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 149299000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Other Special Charges: -398000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Payables: 1464038000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 15846000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 93055000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Pretax Income: 1455147000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: -1729000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -247753000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -1869892000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 644863000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 7135658000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 152333000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 993000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 993000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -66992000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 70744000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 3796974000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 315362000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 621000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 374370000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 466749000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Share Issued: 51844960.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Special Income Charges: 398000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 4760131000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 4755764000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 2506872.76
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Tax Provision: 375759000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.26
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 238771000.00
APCOTEXIND.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -350188000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Total Assets: 8034411000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 6007777000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Total Debt: 1517914000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 4760131000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Total Expenses: 9258353000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 3274280000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 4809268000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 1474587000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 5300000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 14516000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 9708000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 9708000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Work In Process: 54313000.00
APCOTEXIND.NS balance_sheet (annual, 2023-03-31) — Working Capital: 1425450000.00
APCOTEXIND.NS income_statement (annual, 2023-03-31) — Write Off: -1490000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — +Operating Expense: 2471421000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — +Total Revenue: 11132037000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 1347843000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 2030319000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -1122291000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 260027000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -42212000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Amortization: 2898000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 2898000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Assets Held For Sale Current: 0.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 886536000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 51844960.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Basic EPS: 10.39
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 300676000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 779154000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -277730000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 55799000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 103690000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 151940000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 377274000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -281632000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 151940000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -199378000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -13295000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -3558000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Change In Payable: 353115000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -766848000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -629964000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 75876000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Common Stock: 103690000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 5217432000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 78843000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 7836499000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Current Assets: 4262656000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 10309000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Current Debt: 892046000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 902355000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 2722042000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 15164000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Depreciation: 312463000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 315361000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 315361000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 312463000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 51844960.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Diluted EPS: 10.39
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 538787000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 20735000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 2013000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — EBIT: 893134000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — EBITDA: 1208495000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — End Cash Position: 376552000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -129889000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 455562000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 124389000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -14282000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 107923000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 4886000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 2072531000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 5039002000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Gross Profit: 3295538000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Interest Expense: 147955000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 147955000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Interest Income: 5180000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 5180000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -153370000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 5291000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Inventory: 1250275000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 7045088000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -196354000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Investment Properties: 14795000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 886536000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 0.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 91854000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 45490000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 935610000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 981100000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 0.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: 0.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 31045000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 3328474000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Net Debt: 1675716000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -951000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Net Income: 538787000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 538787000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 538787000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 538787000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 538787000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 745179000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 538787000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Net Interest Income: -150962000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 70162000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 309278000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 0.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -150962000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: -1000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: 3468000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Net PPE: 3916711000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -277288000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 309278000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 5212546000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 199035000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 31045000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 134915000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 1195947000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Normalized Income: 529714415.73
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 402119000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Operating Income: 824117000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Operating Revenue: 11132037000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 51844960.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 348290000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 2100000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 5113742000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 4886000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 14724000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 147495000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 1000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 3808000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 1043208000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Other Payable: 401254000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Other Properties: 760677000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 203754000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 225334000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Other Special Charges: -345000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Payables: 1784726000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 15164000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 105515000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Pretax Income: 745179000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 4247000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -184699000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -277730000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 725735000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 7836499000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 315361000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 483000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 483000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: 0.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 90404000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 4122707000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 254861000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 442000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 448051000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 555974000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Share Issued: 51844960.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Special Income Charges: 345000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 5217432000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 5212546000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 3475415.73
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Tax Provision: 206392000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.28
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 205115000.00
APCOTEXIND.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -164966000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Total Assets: 9220500000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 6153042000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Total Debt: 1883455000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 5217432000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Total Expenses: 10307920000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 4003068000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 4957844000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 1281026000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 8187000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 14894000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 12548000.00
APCOTEXIND.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 12548000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Work In Process: 54254000.00
APCOTEXIND.NS balance_sheet (annual, 2024-03-31) — Working Capital: 1540614000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 1609918000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 2378876000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 1024731000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 50748000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 103690000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 167838000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 532763000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 103690000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 5437561000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 119495000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 4814255000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 10728000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 1308179000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 1318907000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 3252094000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 14407000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 4517000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 3812497000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 1359440000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 7525336000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Investment Properties: 14631000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 1024731000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 40020000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 779596000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 819616000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 30596000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 1919937000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 3812497000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 5433044000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 226056000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 51844960.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 538345000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 92219000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 5333871000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 94928000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 3693002000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 4831000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 364925000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Payables: 1609918000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 51844960.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 5437561000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 5433044000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 9816069000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 6217157000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 2138523000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 5437561000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 4378508000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 5001814000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 1126414000.00
APCOTEXIND.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 1562161000.00
APCOTEXIND.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
APCOTEXIND.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
APCOTEXIND.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — +Operating Expense: 2580030000.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 779646000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — +Total Revenue: 13775308000.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 3493962000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 1876444000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1876444000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 2540352000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 2540352000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -1442854000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1442854000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 260027000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 260027000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -54989000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -54989000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Amortization: 3200000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 3200000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Assets Held For Sale Current: 344000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 344000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 833980000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 833980000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 51844960.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 51873065.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Basic EPS: 10.43
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 3.23
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 376552000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 953237000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 953237000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -499520000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 45490000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 45490000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 103690000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 103690000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 265419000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 265419000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 492007000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 492007000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -281500000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 265419000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 265419000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -127479000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -2725000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -15941000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Change In Payable: 417692000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -577627000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -306080000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 114851000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Common Stock: 103690000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 103690000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 5531837000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 5531837000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 119427000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 119427000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 10363396000.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2435015000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Current Assets: 5083754000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 5083754000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 11164000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 11164000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Current Debt: 1224309000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 1224309000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 1235473000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1235473000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 3508112000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 3508112000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 24335000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 24335000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Depreciation: 412571000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 415771000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 415771000.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 105287000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 412571000.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 105287000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 51844960.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 51873065.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Diluted EPS: 10.43
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 3.23
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 540646000.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 167550000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 25426000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 25426000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 2468000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — EBIT: 924621000.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — EBIT: 288592000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — EBITDA: 1340392000.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — EBITDA: 393879000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — End Cash Position: 491403000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -444866000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 407372000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 407372000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 347683000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -20189000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 98737000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 3820000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 3820000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 2595341000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 2595341000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 5404474000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 5404474000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Gross Profit: 3411912000.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 1058947000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Interest Expense: 162163000.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 43840000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 162163000.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 43840000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Interest Income: 6529000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 6529000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -172820000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 5920000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Inventory: 1377754000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 1377754000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 7379728000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 7379728000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -287486000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Investment Properties: 14468000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Investment Properties: 14468000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 833980000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 833980000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 91854000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 91854000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 34326000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 34326000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 623582000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 623582000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 657908000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 657908000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -312500000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 36508000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 36508000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 3439098000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 3439098000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Net Debt: 1582472000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 1582472000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 12772000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Net Income: 540646000.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — Net Income: 167550000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 540646000.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 167550000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 540646000.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 167550000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 540646000.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 167550000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 540646000.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 167550000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 762458000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 540646000.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 167550000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Net Interest Income: -166709000.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -43840000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 113333000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 19763000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -312500000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -166709000.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -43840000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: 4026000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Net PPE: 3961620000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 3961620000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -413233000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 332263000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 5528017000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 5528017000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 205722000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 205722000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 36508000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 36508000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 70054000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 70054000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 1320735000.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 393879000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Normalized Income: 526707221.30
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 167550000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 847203000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Operating Income: 831882000.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — Operating Income: 279301000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Operating Revenue: 13775308000.00
APCOTEXIND.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 3493962000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 51844960.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 51844960.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 338726000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 338726000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 2100000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 2100000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 5428147000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 5428147000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 3820000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 3820000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 16019000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 16019000.00
APCOTEXIND.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 162683000.00
APCOTEXIND.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 90831000.00
APCOTEXIND.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 90831000.00
APCOTEXIND.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 4877000.00